Compare SHC & INGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHC | INGR |
|---|---|---|
| Founded | 2015 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 6.0B |
| IPO Year | 2020 | 1997 |
| Metric | SHC | INGR |
|---|---|---|
| Price | $17.91 | $97.86 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 7 |
| Target Price | $22.61 | ★ $119.50 |
| AVG Volume (30 Days) | ★ 1.8M | 606.0K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 3.41% |
| EPS Growth | ★ 68.75 | 15.14 |
| EPS | 0.28 | ★ 4.01 |
| Revenue | $1,163,617,000.00 | ★ $7,219,000,000.00 |
| Revenue This Year | $7.16 | N/A |
| Revenue Next Year | $5.91 | $1.96 |
| P/E Ratio | $64.59 | ★ $24.28 |
| Revenue Growth | ★ 5.74 | N/A |
| 52 Week Low | $13.09 | $93.72 |
| 52 Week High | $19.85 | $123.49 |
| Indicator | SHC | INGR |
|---|---|---|
| Relative Strength Index (RSI) | 42.82 | 51.21 |
| Support Level | $16.74 | $94.04 |
| Resistance Level | $18.77 | $104.60 |
| Average True Range (ATR) | 0.49 | 1.75 |
| MACD | -0.03 | 0.46 |
| Stochastic Oscillator | 24.83 | 69.29 |
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins. The company plans to acquire Tate & Lyle in an all-cash deal that should close in 2027.